Mats Henriksson - Fresenius Member of the Management Board, CEO Fresenius Kabi
| FSNUY Stock | USD 7.39 0.10 1.34% |
CEO
Mr. Mats Christer Henriksson is Member of the Management Board and Chief Executive Officer of Business Segment Fresenius Kabi at Fresenius SE Co KGaA since January 1, 2013. He joined the Management Board of Fresenius Kabi on September 1, 1999 and served as President of the region Asia Pacific from 2001 until February 2012. Since March 1, 2012 he had been Deputy Chairman of the Management Board of Fresenius Kabi AG and was appointed as CEO effective as of January 1, 2013. Prior to joining the Fresenius Group, Mats Henriksson held several management positions in controlling and finance at Pharmacia. He is Chairman of the Supervisory Board of Fresenius Kabi Austria GmbH, Member of the supervisory Boards of Fresenius Kabi Espana S.A.U. and Labesfal Laboratorios Almiro, S.A. He is also Chairman of the Administrative Board of Fresenius Kabi Italia S.p.A., and Member of the Boards of Directors of Fenwal, Inc. and FHC Ltd., among others. Mats Henriksson holds a BS degree in Business Administration and Economics from Gothenburg School of Economics in Sweden. since 2013.
| Age | 51 |
| Tenure | 11 years |
| Phone | 49 6172 608 2487 |
| Web | https://www.fresenius.com |
Fresenius Management Efficiency
The company has return on total asset (ROA) of 0.0292 % which means that it generated a profit of $0.0292 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0793 %, meaning that it generated $0.0793 on every $100 dollars invested by stockholders. Fresenius' management efficiency ratios could be used to measure how well Fresenius manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 8 records | CEO Age | ||
| Debra Osteen | Acadia Healthcare | 62 | |
| Christopher Christensen | The Ensign Group | 55 | |
| April Anthony | Encompass Health Corp | 53 | |
| Stephen Flatt | National HealthCare | 68 | |
| Bassam Damaj | InnovAge Holding Corp | 47 | |
| Mark Tarr | Encompass Health Corp | 62 | |
| Patrick Blair | InnovAge Holding Corp | 53 | |
| David Chernow | Select Medical Holdings | 67 | |
Management Performance
| Return On Equity | 0.0793 | |||
| Return On Asset | 0.0292 |
Fresenius SE Leadership Team
Elected by the shareholders, the Fresenius' board of directors comprises two types of representatives: Fresenius inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Fresenius. The board's role is to monitor Fresenius' management team and ensure that shareholders' interests are well served. Fresenius' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Fresenius' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Rachel Empey, CFO, Member of the Management Board | ||
| KlausPeter Mueller, Member of the Supervisory Board | ||
| Roland Berger, Member of the Supervisory Board | ||
| Mats Henriksson, Member of the Management Board, CEO Fresenius Kabi | ||
| Michael Albrecht, Member of the Supervisory Board | ||
| Michael Sen, Pres CEO | ||
| Sara Hennicken, Chief Officer | ||
| Ernst Wastler, Member of the Management Board - Fresenius Management SE and CEO of Fresenius Vamed | ||
| Dieter Schenk, Deputy Chairman of the Supervisory Board and Lawyer and Tax Consultant | ||
| Frauke Lehmann, Member of the Supervisory Board | ||
| Matthias Link, Sr Communications | ||
| Markus Georgi, Senior Vice President Investor Relations | ||
| Dario Ilossi, Member of the Supervisory Board, Employee Representative | ||
| Stephan Sturm, CFO of Fresenius Management SE and Member of the Management Board - Fresenius Management SE | ||
| Gregor Zuend, Member of the Supervisory Board | ||
| Konrad Koelbl, Member of the Supervisory Board | ||
| Niko Stumpfoegger, Deputy Chairman of the Supervisory Board, Employee Representative | ||
| Francesco Meo, Member of the Management Board - Fresenius Management SE and CEO of Fresenius Helios | ||
| Bernd Behlert, Independent Member of the Supervisory Board | ||
| Ulf Schneider, Chairman of the Management Board - Fresenius Management SE, CEO of Fresenius Management SE and President of Fresenius Management SE | ||
| Oscar Paco, Member of the Supervisory Board | ||
| Helen Giza, Member SE | ||
| Dieter Reuss, Member of the Supervisory Board | ||
| Sebastian Biedenkopf, HR, Officer | ||
| Gerhard Roggemann, Member of the Supervisory Board | ||
| Stefan Schubert, Member of the Supervisory Board, Employee Representative | ||
| Hauke Stars, Member of the Supervisory Board | ||
| Stefanie Lang, Member of the Supervisory Board | ||
| Iris LoewFriedrich, Member of the Supervisory Board | ||
| Juergen Goetz, Chief Legal and Compliance Officer, Labor Relations Director, Member of the Management Board | ||
| Michael Diekmann, Member of the Supervisory Board | ||
| Rice Powell, Member of the Management Board | ||
| Carla Kriwet, Members SE | ||
| Gerd Krick, Chairman of the Supervisory Board | ||
| Rainer Stein, Member of the Supervisory Board, Employee Representative |
Fresenius Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Fresenius a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0793 | |||
| Return On Asset | 0.0292 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 43.74 B | |||
| Shares Outstanding | 2.25 B | |||
| Price To Earning | 7.33 X | |||
| Price To Book | 0.71 X | |||
| Price To Sales | 0.38 X | |||
| Revenue | 37.52 B |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Fresenius in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Fresenius' short interest history, or implied volatility extrapolated from Fresenius options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fresenius SE Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Fresenius Pink Sheet analysis
When running Fresenius' price analysis, check to measure Fresenius' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius is operating at the current time. Most of Fresenius' value examination focuses on studying past and present price action to predict the probability of Fresenius' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius' price. Additionally, you may evaluate how the addition of Fresenius to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |